CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

Overview of attention for article published in Trials, April 2018

Altmetric Badge

Mentioned by

blogs: 1 blog

twitter: 18 X users

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 72 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 22 X posts from 18 X users, with an upper bound of 27,542 followers.

CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of n#ivolumab in patients with relapsed mesothelioma: study protocol for a RCT https://t.co/3TzE1pmTiD #mesothelioma

11 May 2018

Reply Repost Favourite

RT @UoS_WISHlab: CONFIRM trial design published; new #mesothelioma trial run from @SouthamptonCTU @UHSFT @uniofleicester https://t.co/rTCx…

04 May 2018

Reply Repost Favourite

CONFIRM trial design published; new #mesothelioma trial run from @SouthamptonCTU @UHSFT @uniofleicester https://t.co/rTCxxNK6J1 https://t.co/42xkk75NeT

04 May 2018

Reply Repost Favourite

RT @grandmamavis: The Confirm trial Papers has just been Published be one of the first to read x #mesothelioma #Clinicaltrials #NHS https:/…

26 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.